|
Radiology HomeDepartment OverviewFacultyResidencyFellowshipsNeuroradiology |
|
|
|||||||||||||||
|
|
|
| Figure 1: Post-gadolinium axial T1WI shows thickening as well as enhancement of distal half of the right optic nerve. | Figure 2: Coronal T1-weighted MR image shows thickened and hyperintense right optic nerve. |
Diagnosis: Right optic neuritis/pseudotumor
Discussion: The
orbital pseudotumor is defined as non-specific, non-neoplastic
inflammatory process of the orbit without identifiable local/systemic
cause. The disorder was first described by Birch-Hirschfield in
1905 [1]. This is a diagnosis of exclusion based on history, the
clinical course of the disease, and the response to steroid therapy,
laboratory tests, and biopsy in a limited number of cases. There
is a group of disease entities that can mimic pseudotumors such
as lymphoid tumors, thyroid orbitopathy, sarcoidosis, and other
granulomatous diseases.
Each of these abnormalities, or at least components of each, has
been included under the umbrella term pseudotumor at sometime during
the last few decades. Currently the term pseudotumor should be reserved
for idiopathic orbital inflammatory syndrome.
Idiopathic orbital inflammatory syndrome accounts for 4.7% to 6.3%
of orbital disorders and the disease is more prevalent in adults
than pediatric population. The pathogenesis of the disease remains
elusive but several lines of evidence point to immune mediated processes
as the likely underlying mechanism. Orbital pseudotumor may have
protean clinical manifestations. The most common being unilateral,
sudden onset ocular pain, proptosis and impaired/loss of vision.
Some presentation of idiopathic orbital inflammatory syndrome may
mimic conditions such as orbital cellulitis [2].
Idiopathic orbital inflammatory syndrome
is usually confined to orbit, rarely may extend intracranially. However,
when confined to orbit,
may be multifocal, involving more than one structure. Most authors
recognize it as, (a) myositis, (b) dacrycystadenitis, (c) periscleritis,
(d) perineuritis, or (e) diffuse group. The diffuse group refers
to the patients in whom involvement of orbital fat predominates.
It
is the diffuse variety which simulates lymphomatous infiltration,
and biopsy is helpful in establishing the diagnosis in such cases
[3].
In the subgroup of perineuritis, there is
inflammation of the sheath surrounding the optic nerve. In addition
to idiopathic orbital inflammatory
syndrome, optic neuropathy may be seen in number of conditions such
as multiple sclerosis, optic nerve sheath meningioma, autoimmune
disease (systemic lupus erythematosus), post viral infections (herpes,
chicken pox, rubella, etc.), and infective conditions as syphilis/toxoplasmosis/Lynne
disease. Radiation optic neuropathy is another rare cause. It is
important to diagnose the underlying cause of the optic neuritis
since prognosis and treatment varies for each condition [4].
Acute pain is an important feature of pseudotumors. Multiple sclerosis
usually presents with gradual painless loss of vision. Immune markers
with other systemic presentation would negate the diagnosis of pseudotumors.
Viral neuritis is usually seen 10-14 days after the primary illness.
The index case was found negative for antinuclear antibodies and
there was no history of preceding illness. Since patient presented
with acute pain with impaired vision without any systemic involvement,
hence a diagnosis of optic neuritis /pseudotumor was considered.
CT may show some enlargement of optic nerve, usually with some degree
of enhancement. MR imaging will depict the thickening of the optic
nerve. There may be few streaky densities in contiguous orbital fat.
Post contrast fat-suppressed, T1-weighted MR images may be the best
technique to demonstrate optic neuritis as seen in index case. Contrast
enhancement is often subtle or present in short segment of nerve,
particularly in intracanalicular portion of the nerve.
Steroids show a dramatic effect in the treatment of acute cases of pseudotumors
and usually reverse the changes completely.
References:
|
|
||
©Copyright University of Rochester Medical Center, 1999-2006. Disclaimer. For questions or suggestions concerning the content of these pages, contact the URMC Webmaster.